PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke

[Figure: see text].

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2021-09, Vol.52 (9), p.e545-e547
Main Authors: Nativel, Brice, Ramin-Mangata, Stéphane, Couret, David, Planesse, Cynthia, Roche, Mathias, Gallo, Antonio, Meilhac, Olivier, Lambert, Gilles, Bourane, Steeve
Format: Article
Language:English
Subjects:
Animals
Atherosclerosis - genetics
Atherosclerosis - metabolism
Brain Ischemia - genetics
Brain Ischemia - metabolism
Hemorrhage - genetics
Ischemic Stroke - genetics
Ischemic Stroke - metabolism
Life Sciences
Mice
Mice, Obese
Proprotein Convertase 9 - genetics
Proprotein Convertase 9 - metabolism
Risk Factors
Stroke - genetics
Stroke - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Figure: see text].
ISSN:0039-2499
1524-4628
DOI:10.1161/STROKEAHA.121.035677